Lesion conspicuity and contrast kinetics as predictors to differentiate benign and malignant breast lesions in contrast-enhanced mammogram

Abstract

Contrast-enhanced mammography (CEM) is a recently developed, cost-effective imaging technique that offers both anatomical and functional breast imaging. Lesion conspicuity, a newly introduced lexicon in the ACR BIRADS supplementary atlas on CEM (2022), lacks sufficient data to correlate with malignancy likelihood. The feasibility of assessing contrast kinetics with CEM remains uncertain, and there is a scarcity of available data. Our research aims to address these gaps. Two radiologists, blinded to pathological reports, independently evaluated 504 CEM enhanced breast lesions with histopathology reports, out of which 176 were benign and 328 were malignant. Subjective qualitative assessment of lesion conspicuity and contrast kinetics was done for each enhancing lesion. The lesion conspicuity was classified as low, moderate, or high. The kinetic behavior of each lesion was categorized into either persistent, plateau, or washout. The distribution of lesion conspicuity among benign and malignant lesions, respectively, was as follows: for low conspicuity, 74.4% versus 25.6%; for moderate conspicuity, 30.6% versus 69.4%; and for high conspicuity, 8.4% versus 91.6%. Regarding contrast kinetics and their distribution between benign and malignant lesions, persistent kinetics was detected in 95.6% compared to 4.4%, plateau kinetics in 43.4% versus 56.6%, and washout kinetics in 3.5% versus 96.5%. Statistically significant differences in distribution between benign and malignant lesions were observed for both lexicons (P < 0.001). The inter-observer agreement for lesion conspicuity (kappa = 0.97) and contrast kinetics (kappa = 0.92) was deemed excellent. The addition of lesion conspicuity and contrast kinetics as lexicons in CEM could enhance its diagnostic accuracy.